RCS - Agronomics Limited - Agronomics welcomes Senior Investment Associate

AgronomicsAnnouncement

24/02/2022 07:18

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220224:nRSX6270Ca&default-theme=true

RNS Number : 6270C  Agronomics Limited  24 February 2022

Agronomics Limited (https://agronomics.im/)

("Agronomics" or the "Company")

 

Agronomics welcomes Hamood Al Fanna as a Senior Investment Associate

Agronomics Limited (AIM:ANIC), a leading listed company focused on cellular
agriculture, is pleased to announce the appointment of Hamood Al Fanna, who
has joined the Company's advisory team as a Senior Investment Associate. Based
in Oman, Hamood was formerly a venture investor at IDO Investments
(https://ido.om/) a global investment firm focused on innovative growth stage
start-ups. At IDO Investments, Hamood focused on the biotechnology and
healthcare sectors. Hamood's arrival will support the advisory team's
recommendations to the Company for investments in promising companies in
cellular agriculture, and also help raise awareness of cellular agriculture
in the Gulf Cooperation Council region, noting the potential of this
technology to vastly improve nutrition security in harsher climates, where the
majority of food is imported.

 

Jim Mellon, Non-executive Director of Agronomics commented:-

 

"We are pleased to welcome Hamood to Agronomics' growing advisory team. His
experience of investing in biotech, alongside his passion for cellular
agriculture, makes him the perfect candidate to augment the range of expert
specialists we now have available to draw upon, and who are placed at the
forefront of this fast-moving, and essential, field."

 

About Agronomics (https://agronomics.im/)

Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of 20 companies at the Pre-Seed to Series C stage in this rapidly
advancing sector. It seeks to secure minority stakes in companies owning
technologies with defensible intellectual property that offer new ways of
producing food and materials with a focus on products historically derived
from animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well as
addressing human health, animal welfare and environmental damage. This
disruption will decouple supply chains from the environment and animals, as
well as being fundamental to feeding the world's expanding population. A full
list of Agronomics' portfolio companies is available
at https://agronomics.im/
(https://clicktime.symantec.com/368cVqxx3R6vTFuHpf6MSE66Gi?u=https%3A%2F%2Fagronomics.im%2F)
.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter, or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food
Institute's estimate that a US $1.8 trillion investment will be required in
order to produce just 10% of the world's protein using this technology, means
that we are on the cusp of a multi-decade flow of capital to build out
manufacturing facilities. Funding in the field of cellular agriculture is
accelerating, however still less than US$ 2 billion has been invested
worldwide since the industry's inception in 2016.

 

For further information please contact:

 Agronomics                                       Beaumont              Cenkos                Peterhouse Capital

 Limited                                          Cornish Limited       Securities Plc        Limited               TB Cardew
 The Company                                      Nomad                 Joint Broker          Joint Broker          Public Relations
 Richard Reed                                     Roland Cornish        Giles Balleny         Lucy Williams         Ed Orlebar

 Denham Eke                                       James Biddle          Michael Johnson       Charles Goodfellow    Joe McGregor
 +44 (0) 1624 639396                              +44 (0) 207 628 3396  +44 (0) 207 397 8900  +44 (0) 207 469 0936  +44 (0) 20 7930 0777

 info@agronomics.im (mailto:info@agronomics.im)                                                                     +44 (0) 7738 724 630

                                                                                                                    agronomics@tbcardew.com (mailto:agronomics@tbcardew.com)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRADXLFLLLLEBBD